NCT06653101

Effect of Akkermansia Muciniphila Akk11 on Metabolic and Gut Health in Overweight and Obese Subjects

Effect of Akkermansia Muciniphila Akk11 on Metabolic and Gut Health in Overweight and Obese Subjects: a Randomized, Double-blind, Placebo-controlled Trial

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 110 (actual)
• Sponsor: Wecare Probiotics Co., Ltd. · Industry
• Sex: All
• Age: 18 Years – 45 Years
• Healthy volunteers: Accepted

Summary

To assess the efficacy and safety of the use of probiotics as a food supplement compared to placebo in regulating body metabolism and gut microbiota in overweight or obese subjects.

Conditions

• Overweight or Obesity

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Probiotic	The trial phase of this study lasted 8 weeks, and each patient will make 3 visits (week 0, week 4, week 8)
DIETARY_SUPPLEMENT	Placebo	The trial phase of this study lasted 8 weeks, and each patient will make 3 visits (week 0, week 4, week 8)

Timeline

• Start date: 2024-10-20
• Primary completion: 2024-12-05
• Completion: 2025-03-20
• First posted: 2024-10-22
• Last updated: 2025-11-18

Locations

1 site across 1 country: China